Ada3 requirement for HAT recruitment to estrogen receptors and estrogen-dependent breast cancer cell proliferation (Cancer Research (2007) 67, (11789-11797))

A. Germaniuk-Kurowska, A. Nag, Xiangshan Zhao, M. Dimri, Hamid Band, Vimla Band

Research output: Contribution to journalComment/debate

Original languageEnglish (US)
Number of pages1
JournalCancer Research
Volume68
Issue number5
DOIs
StatePublished - Mar 1 2008

Fingerprint

Estrogen Receptors
Estrogens
Cell Proliferation
Breast Neoplasms
Research
Neoplasms

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Ada3 requirement for HAT recruitment to estrogen receptors and estrogen-dependent breast cancer cell proliferation (Cancer Research (2007) 67, (11789-11797)). / Germaniuk-Kurowska, A.; Nag, A.; Zhao, Xiangshan; Dimri, M.; Band, Hamid; Band, Vimla.

In: Cancer Research, Vol. 68, No. 5, 01.03.2008.

Research output: Contribution to journalComment/debate

@article{e7f6225fcebb422ab1f45d92e08e8cb5,
title = "Ada3 requirement for HAT recruitment to estrogen receptors and estrogen-dependent breast cancer cell proliferation (Cancer Research (2007) 67, (11789-11797))",
author = "A. Germaniuk-Kurowska and A. Nag and Xiangshan Zhao and M. Dimri and Hamid Band and Vimla Band",
year = "2008",
month = "3",
day = "1",
doi = "10.1158/0008-5472.CAN-68-5-COR1",
language = "English (US)",
volume = "68",
journal = "Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",
number = "5",

}

TY - JOUR

T1 - Ada3 requirement for HAT recruitment to estrogen receptors and estrogen-dependent breast cancer cell proliferation (Cancer Research (2007) 67, (11789-11797))

AU - Germaniuk-Kurowska, A.

AU - Nag, A.

AU - Zhao, Xiangshan

AU - Dimri, M.

AU - Band, Hamid

AU - Band, Vimla

PY - 2008/3/1

Y1 - 2008/3/1

UR - http://www.scopus.com/inward/record.url?scp=40449139212&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=40449139212&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-68-5-COR1

DO - 10.1158/0008-5472.CAN-68-5-COR1

M3 - Comment/debate

VL - 68

JO - Cancer Research

JF - Cancer Research

SN - 0008-5472

IS - 5

ER -